Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Abstracts
Urology
2
Mins
9 May 2017
Impact of Vesomni™ on Quality of Life of Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Routine Clinical Practice: Interim Results from the Europa Study
Lower urinary tract symptoms (LUTS) affect ˜44% of males worldwide1 and can negatively impact quality of life (QoL).
Urology
1
Mins
9 May 2017
Incidental Prostate Cancer (PT1A-PT1B) Detection at Benign Prostatic Hyperplasia Surgery in the Modern Era: Are we Modifying the Detection Rate?
Prior to the prostate-specific antigen (PSA) era, up to 27% of prostate cancers (PCas) were detected incidentally at the time of transurethral resection…
Urology
2
Mins
9 May 2017
Clinical Profile of Amyotrophic Lateral Sclerosis Patients with Lower Urinary Tract Symptoms and Neurogenic Bladder. A Cross-Sectional Study
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that typically involves upper and lower motor neurons.
Urology
1
Mins
9 May 2017
Thulium Vapo-Enucleation of the Prostate Versus Holmium Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a Prospective Randomised Trial
Since the introduction of holmium laser enucleation of the prostate (HoLEP) into the armamentarium of benign prostatic hyperplasia (BPH) treatment, HoLEP…
Urology
1
Mins
9 May 2017
Supracostal Access for Percutaneous Nephrolithotomy in Modified Supine Position: Feasibility, Safety, and Efficacy
Percutaneous nephrolithotomy (PCNL) has become the treatment of choice for large and staghorn renal calculi.
Urology
1
Mins
9 May 2017
A Likert Analysis of Double J Stent-Related Urinary Symptoms Assessed by the Ureteric Stent Symptom Questionnaire after Semi-Rigid and Flexible Ureteroscopy
Many urologists still use double J ureteral stents at the end of semi-rigid and flexible ureteroscopy (ureteroscopic lithotripsy [URS] and retrograde…
Urology
1
Mins
9 May 2017
Redo Urethroplasty after Unsuccessful Urethral Reconstruction with Buccal Mucosal Graft
Substitution urethroplasty is the treatment of choice for patients with recurrent, extended urethral stricture, as the results of the still highly…
Urology
1
Mins
9 May 2017
Validation of Tumour Necrosis Factor Alpha as the Top Upstream Regulator of Bladder Remodelling During Outlet Obstruction-Induced Lower Urinary Tract Dysfunction
MicroRNAs (miRNAs) are small non-coding regulatory RNAs that are altered in patients with lower urinary tract dysfunctions (LUTD).
Loading posts...
« Previous
1
…
110
111
112
113
114
…
130
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View